Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Moleculin Biotech, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 19 | 16 | −3 |
| Shares | 258.5K | 313.7K | +55.3K (+21.4%) |
| Value | $1.53M | $1.10M | −$423.7K (−27.7%) |
New holders (1)
Institutions that held Moleculin Biotech, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 33,754 | $118.8K | 0.00% |
Sold out (4)
Institutions that held Moleculin Biotech, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| FWL Investment Management, LLC | 278 | $1.64K |
| Wells Fargo & Company | 19 | $112 |
| GWM Advisors LLC | 1 | $6 |
| NBC Securities, Inc. | 14 | – |